Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.

MLA

Gage, B. F., et al. “Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin.” Clinical Pharmacology and Therapeutics, vol. 84, no. 3, Sept. 2008, pp. 326–31. EBSCOhost, https://doi.org/10.1038/clpt.2008.10.

APA

Gage, B. F., Eby, C., Johnson, J. A., Deych, E., Rieder, M. J., Ridker, P. M., Milligan, P. E., Grice, G., Lenzini, P., Rettie, A. E., Aquilante, C. L., Grosso, L., Marsh, S., Langaee, T., Farnett, L. E., Voora, D., Veenstra, D. L., Glynn, R. J., Barrett, A., & McLeod, H. L. (2008). Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clinical Pharmacology and Therapeutics, 84(3), 326–331. https://doi.org/10.1038/clpt.2008.10

Chicago

Gage, B F, C Eby, J A Johnson, E Deych, M J Rieder, P M Ridker, P E Milligan, et al. 2008. “Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin.” Clinical Pharmacology and Therapeutics 84 (3): 326–31. doi:10.1038/clpt.2008.10.